Denali Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,000
Closed -$20K 400
2021
Q3
$20K Sell
1,000
-5,000
-83% -$102K 0.01% 217
2021
Q2
$121K Hold
6,000
0.05% 153
2021
Q1
$128K Sell
6,000
-52,400
-90% -$1.13M 0.04% 194
2020
Q4
$1.27M Sell
58,400
-19,600
-25% -$382K 0.22% 131
2020
Q3
$1.38M Sell
78,000
-47,500
-38% -$884K 0.27% 117
2020
Q2
$2.36M Sell
125,500
-96,300
-43% -$1.71M 0.46% 73
2020
Q1
$3.83M Sell
221,800
-17,800
-7% -$372K 0.83% 42
2019
Q4
$5.06M Buy
239,600
+12,700
+6% +$257K 0.72% 49
2019
Q3
$4.44M Sell
226,900
-1,700
-0.7% -$31.2K 0.62% 53
2019
Q2
$3.99M Sell
228,600
-96,600
-30% -$1.74M 0.6% 55
2019
Q1
$6.02M Sell
325,200
-57,300
-15% -$1.02M 0.96% 44
2018
Q4
$6.15M Buy
382,500
+112,800
+42% +$1.78M 1.03% 44
2018
Q3
$4.02M Buy
269,700
+63,600
+31% +$928K 0.59% 51
2018
Q2
$2.89M Buy
206,100
+158,600
+334% +$2.1M 0.44% 59
2018
Q1
$618K Hold
47,500
0.1% 99
2017
Q4
$655K Hold
47,500
0.1% 102
2017
Q3
$624K Buy
+47,500
New +$612K 0.1% 93

Other funds holding MPT

Denali Advisors's MPT Position: Q4 2021 in Review

Denali Advisors sold out of Medical Properties Trust (MPT) in Q4 2021, closing a stake of 1,000 shares — an estimated $20K sold.

Denali Advisors first reported a position in MPT in Q3 2017 and held it in 17 quarters. The position peaked at $6.15M in Q4 2018. 634 funds tracked by Wall St. Rank hold MPT as of Q4 2021.

  • Denali Advisors reported no remaining Medical Properties Trust position as of Q4 2021 after selling out during the quarter.
  • Denali Advisors sold 1,000 Medical Properties Trust shares in Q4 2021, an estimated $20K.
  • Denali Advisors first reported a position in Medical Properties Trust in Q3 2017 and held it in 17 quarters.
  • Denali Advisors's Medical Properties Trust position peaked at $6.15M in Q4 2018.
  • 634 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2021.

Based on Denali Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.